{"id":"NCT01074268","sponsor":"Novo Nordisk A/S","briefTitle":"Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes","officialTitle":"NN1250-3585: A Trial Investigating the Efficacy and Safety of NN1250 Compared to Insulin Detemir in Subjects With Type 1 Diabetes Mellitus in a Basal/Bolus Treatment Regimen / NN1250-3725: An Extension Trial to NN1250-3585 Investigating Safety and Efficacy of NN1250 Compared to Insulin Detemir in Subjects With Type 1 Diabetes Mellitus in a Basal/Bolus Treatment Regimen (BEGINâ„¢: BB T1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02","primaryCompletion":"2010-12","completion":"2010-12","firstPosted":"2010-02-24","resultsPosted":"2015-11-16","lastUpdate":"2017-03-06"},"enrollment":456,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin detemir","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]}],"arms":[{"label":"IDeg OD","type":"EXPERIMENTAL"},{"label":"IDet","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Asia, Europe, Japan and South America. The aim of the trial is to compare the efficacy, safety and tolerability of NN1250 (insulin degludec (\\[Deg\\]) with insulin detemir (IDet), both combined with insulin aspart.\n\nThe main period is registered internally at Novo Nordisk as NN1250-3585 while the extension period is registered as NN1250-3725.","primaryOutcome":{"measure":"Main Trial (Primary Endpoint): Change in Glycosylated Haemoglobin (HbA1c) After 26 Weeks of Treatment","timeFrame":"Week 0, Week 26","effectByArm":[{"arm":"IDeg OD","deltaMin":-0.73,"sd":0.88},{"arm":"IDet OD","deltaMin":-0.65,"sd":0.86}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":69,"countries":["Argentina","Brazil","Finland","India","Italy","Japan","North Macedonia","United Kingdom"]},"refs":{"pmids":["24702700","26435472"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":301},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Gastroenteritis","Cough"]}}